Immune responses to tetanus vaccine unchanged for RA patients on rituximab
Thursday, January 7, 2010 - 00:42
in Health & Medicine
Researchers from Johns Hopkins University determined that immune responses to the tetanus vaccine were not changed when rituximab in combination with methotrexate (MTX) was compared with MTX alone in patients with rheumatoid arthritis (RA). Responses to a pneumococcal vaccination (Pneumovax(R) pneumonia vaccine), however, were reduced in RA patients with rituximab. Complete findings of this study are published in the January 2010 issue of Arthritis and Rheumatism, a journal of the American College of Rheumatology...